UK Supercomputer Develops AI Vaccines

Isambard-AI, a £225 million supercomputer at the University of Bristol, is transforming medical research with its ability to develop vaccines for diseases like Alzheimer's, enhance treatments for conditions such as heart disease and cancer, and improve melanoma detection across diverse skin tones. Set to launch by Summer 2025, it blends powerful computing with sustainable design—boosting the UK’s leadership in AI-driven healthcare.

Read More